Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Market Analysis & Valuation

UpdatedJan 22, 2026
DataAggregated Company Financials
Companies133
  • 7D-2.2%
  • 3M8.2%
  • 1Y-15.4%
  • YTD5.5%

Over the last 7 days, the market has dropped 2.2%, driven by pullbacks in every sector, especially the Healthcare sector. The market has dropped 15% in the last year. As for the next few years, earnings are expected to grow by 5.7% per annum.

Trending IndustriesBiotech

Market Valuation and Performance

Has the Danish Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 22 Jan 2026DKK 4.4tDKK 2.0tDKK 260.8b16.8x16.9x2.3x
Sat, 20 Dec 2025DKK 4.1tDKK 1.9tDKK 260.8b15.8x15.7x2.1x
Mon, 17 Nov 2025DKK 4.0tDKK 2.0tDKK 262.3b14.5x15.2x2x
Wed, 15 Oct 2025DKK 4.1tDKK 1.9tDKK 287.8b14.9x14.2x2.1x
Fri, 12 Sep 2025DKK 4.0tDKK 1.9tDKK 287.2b14.9x13.8x2.1x
Sun, 10 Aug 2025DKK 3.9tDKK 1.9tDKK 268.4b15.5x14.5x2.1x
Tue, 08 Jul 2025DKK 4.4tDKK 1.9tDKK 261.8b15.4x16.8x2.4x
Thu, 05 Jun 2025DKK 4.6tDKK 1.9tDKK 263.3b15.6x17.5x2.5x
Sat, 03 May 2025DKK 4.5tDKK 1.9tDKK 259.0b14.6x17.3x2.4x
Mon, 31 Mar 2025DKK 4.6tDKK 1.9tDKK 260.6b14.7x17.5x2.4x
Wed, 26 Feb 2025DKK 5.5tDKK 1.9tDKK 264.9b14.1x20.7x2.9x
Fri, 24 Jan 2025DKK 5.0tDKK 1.8tDKK 238.4b14.1x21.2x2.8x
Sun, 22 Dec 2024DKK 5.1tDKK 1.8tDKK 238.2b13.6x21.3x2.8x
Tue, 19 Nov 2024DKK 5.6tDKK 1.8tDKK 237.0b14.1x23.8x3.1x
Thu, 17 Oct 2024DKK 6.2tDKK 1.7tDKK 181.1b15.1x34.1x3.5x
Sat, 14 Sep 2024DKK 6.7tDKK 1.7tDKK 180.1b15.6x37.3x3.9x
Mon, 12 Aug 2024DKK 6.6tDKK 1.7tDKK 182.1b15.8x36.2x3.8x
Wed, 10 Jul 2024DKK 6.8tDKK 1.7tDKK 184.6b15.2x37x4x
Fri, 07 Jun 2024DKK 6.9tDKK 1.7tDKK 184.5b15.1x37.4x4x
Sun, 05 May 2024DKK 6.2tDKK 1.7tDKK 183.4b14.7x34.1x3.7x
Tue, 02 Apr 2024DKK 6.4tDKK 1.7tDKK 192.6b14.8x33.5x3.8x
Thu, 29 Feb 2024DKK 6.2tDKK 1.7tDKK 191.6b13.2x32.4x3.6x
Sat, 27 Jan 2024DKK 5.7tDKK 1.8tDKK 216.9b13.8x26.5x3.2x
Mon, 25 Dec 2023DKK 5.5tDKK 1.8tDKK 216.2b13.4x25.5x3.1x
Wed, 22 Nov 2023DKK 5.4tDKK 1.8tDKK 216.6b13.2x24.9x3x
Fri, 20 Oct 2023DKK 5.3tDKK 1.9tDKK 285.2b12.8x18.5x2.8x
Sun, 17 Sep 2023DKK 5.4tDKK 1.9tDKK 283.6b13.4x19x2.9x
Tue, 15 Aug 2023DKK 5.3tDKK 1.9tDKK 278.7b13.6x19x2.8x
Thu, 13 Jul 2023DKK 4.9tDKK 1.9tDKK 319.3b13.5x15.4x2.6x
Sat, 10 Jun 2023DKK 5.1tDKK 1.9tDKK 325.1b14.3x15.7x2.6x
Mon, 08 May 2023DKK 5.1tDKK 1.9tDKK 312.7b14.2x16.3x2.7x
Wed, 05 Apr 2023DKK 4.9tDKK 1.9tDKK 343.0b14.8x14.3x2.6x
Fri, 03 Mar 2023DKK 4.8tDKK 1.9tDKK 348.8b13.9x13.8x2.5x
Sun, 29 Jan 2023DKK 4.6tDKK 1.9tDKK 354.7b13.8x12.9x2.4x
Price to Earnings Ratio

12.9x


Total Market Cap: DKK 4.6tTotal Earnings: DKK 354.7bTotal Revenue: DKK 1.9tTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Market Price to Earnings3Y Average 22.2x202420252026
Current Market PE
  • Investors are pessimistic on the Danish market, indicating that they anticipate earnings will not grow as fast as they have historically.
  • The market is trading at a PE ratio of 16.9x which is lower than its 3-year average PE of 22.2x.
Past Earnings Growth
  • The earnings for Danish listed companies have declined 9.7% per year over the last three years.
  • Meanwhile revenues have been flat.
  • This means that either the cost of doing business or the level of investment back into businesses is increasing since sales have remained steady while profits have fallen.

Sector Trends

Which sectors have driven the changes within the Danish Market?

DK Market-2.25%
Telecom-0.095%
Consumer Staples-1.57%
Healthcare-1.96%
Financials-1.99%
Industrials-2.44%
Utilities-2.93%
Real Estate-3.11%
Materials-3.41%
Tech-4.21%
Consumer Discretionary-5.23%
Energy-6.10%
Sector PE
  • Investors favour the Tech sector the most for future growth, which is trading close to its 3-year average PE ratio of 52.3x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 56.0% which is higher than its past year's earnings decline of 17.5% per year.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 56% over the next 5 years.
  • This is better than its past earnings decline of 17% per year.
  • In contrast, the Energy sector is expected to see its earnings decline by 35% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
FLS FLSmidthDKK 533.005.3%
+DKK 1.4b		44.8%PE21.2xIndustrials
TRYG TrygDKK 160.800.3%
+DKK 301.2m		1.5%PE20xFinancials
ALMB Alm. BrandDKK 18.460.8%
+DKK 195.7m		23.0%PE25.6xFinancials
RILBA Ringkjøbing LandbobankDKK 1.59k0.4%
+DKK 143.5m		32.8%PB3.4xFinancials
DAB Danske Andelskassers BankDKK 19.651.6%
+DKK 66.9m		42.9%PB1.4xFinancials
See more

Market Insights

Header cover image
Why Didn’t Oil React to Venezuela? 🇻🇪
Stella Ong avatar
Stella Ong
|
|
Maduro is out, the US stepped in… and oil markets barely reacted? Let’s look at why.
Continue reading
Which Markets Will Sink or Swim in 2026? 🌍
Last Week

Which Markets Will Sink or Swim in 2026? 🌍

Latest News

RILBA
DKK 1,587.00
Ringkjøbing Landbobank
7D
0.4%
1Y
32.8%
ALMB
DKK 18.46
Alm. Brand
7D
0.8%
1Y
23.0%
VWS
DKK 178.00
Vestas Wind Systems
7D
-5.6%
1Y
92.2%

VWS: Higher Price View Will Face Pressure From Execution And Margin Risks

Analysts have lifted their price target on Vestas Wind Systems, with one recent move taking it to DKK 173 from DKK 164. The change reflects updates to fair value assumptions, discount rate, revenue growth expectations, profit margin outlook and future P/E inputs.
GMAB
DKK 2,088.00
Genmab
7D
-7.2%
1Y
38.3%

GMAB: Phase 3 Setback And 2026 Readout Will Shape Market Outlook

Genmab’s analyst price target has been lifted by roughly DKK 100 to reflect updated expectations around slightly higher revenue growth and profit margin assumptions, as analysts point to recent target increases from DKK 2,000 to DKK 2,400 and DKK 2,500 as support for a higher fair value range. Analyst Commentary Recent Street research on Genmab reflects a generally constructive stance, with higher price targets and continued attention on upcoming clinical milestones.
NOVO B
DKK 373.85
Novo Nordisk
7D
-1.2%
1Y
-35.7%

Novo Nordisk A/S' (CPH:NOVO B) 26% Share Price Surge Not Quite Adding Up

Jan 17
Novo Nordisk A/S' (CPH:NOVO B) 26% Share Price Surge Not Quite Adding Up
FLS
DKK 533.00
FLSmidth
7D
5.3%
1Y
44.8%
TIV
DKK 614.00
Tivoli
7D
1.7%
1Y
-1.3%
TRYG
DKK 160.80
Tryg
7D
0.3%
1Y
1.5%

TRYG: Recent Downgrade Will Reset Expectations While Keeping Core Franchise Intact

Analysts have trimmed their price target on Tryg from DKK 175 to about DKK 171.60. They cite updated assumptions on discount rates, growth, profitability and valuation multiples, in line with a recent downgrade highlighted in Street research.
GRLA
DKK 1,190.00
GrønlandsBANKEN
7D
2.6%
1Y
51.6%
MAERSK B
DKK 14,845.00
A.P. Møller - Mærsk
7D
-6.0%
1Y
43.4%

MAERSK B: Freight Cycle Uncertainty Will Meet Mixed Margin And Earnings Outlook

Analysts have lifted their fair value estimate for A.P. Møller Mærsk from DKK 15,558 to about DKK 15,882, reflecting updated assumptions on revenue growth, profit margins and future P/E multiples in light of recent target moves, which range from DKK 8,600 to DKK 14,352 across the Street. Analyst Commentary Recent Street research on A.P. Møller Mærsk shows a wide spread in target prices, with several bullish analysts focusing on potential upside scenarios while others remain cautious.
FYNBK
DKK 224.00
Fynske Bank
7D
2.8%
1Y
47.4%
COLO B
DKK 547.40
Coloplast
7D
-4.4%
1Y
-33.3%

COLO B: Sustained Margins And Dividend Payouts Will Support Future Upside

Narrative update The analyst price target for Coloplast has edged up by about DKK 0.30 to reflect slightly higher fair value estimates. Recent Street research shows a mix of views, with some analysts lifting targets toward DKK 535 and others resetting them closer to DKK 640, which has led to modest adjustments to discount rate, revenue growth, profit margin, and future P/E assumptions.
DANSKE
DKK 314.00
Danske Bank
7D
-3.2%
1Y
46.5%

DANSKE: Future Returns Will Reflect Earnings Durability And Easing Legal Overhang

Analysts have nudged their fair value estimate for Danske Bank up from DKK 308 to DKK 310, reflecting a series of recent price target increases (including moves to DKK 295 and DKK 319) and small adjustments in discount rate, profit margin and forward P/E assumptions. Analyst Commentary Recent research on Danske Bank has centered on a cluster of price target revisions, with several large firms updating their views within a short period.
ORSTED
DKK 129.25
Ørsted
7D
-2.9%
1Y
-50.7%
DAB
DKK 19.65
Danske Andelskassers Bank
7D
1.6%
1Y
42.9%
NSIS B
DKK 407.70
Novozymes
7D
-3.4%
1Y
-1.0%